Author:
Kibwage I O,Hoogmartens J,Roets E,Vanderhaeghe H,Verbist L,Dubost M,Pascal C,Petitjean P,Levol G
Abstract
The MICs of erythromycins A, B, C, and D and some of their derivatives were determined against 21 gram-positive and 15 gram-negative microorganisms. Antibacterial activity was confined to gram-positive and very few gram-negative bacteria. Erythromycin B was somewhat less active than erythromycin A, and erythromycin C and D showed about half that activity or even less. Most other derivatives had negligible activity. Determination of potency by diffusion and turbidimetric assays were in line with MICs. The examination of the results of these assays, however, revealed that there are differences between the data of different laboratories, depending on the microorganisms and conditions used.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference15 articles.
1. European Pharmacopoeia. 1983. European pharmacopoeia 2nd. ed. monograph 179. Maisonneuve Sainte Ruffine France.
2. Erythromycin. 11. Des-N-methylerythromycin and N-methyl-C'4-erythromycin;Flynn E. H.;J. Am. Chem. Soc.,1955
3. Erythromycin. I. Properties and degradation studies;Flynn E. H.;J. Am. Chem. Soc.,1954
4. Garrod L. P. H. P. Lambert and F. O'Grady. 1981. Antibiotic and chemotherapy 5th ed. p. 183-190. Churchill Livingstone Ltd. London.
5. Erythromycin;Gribble M. J.;Med. Clin. N. Am.,1982
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献